Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine T Murray

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Cardiac Electrophysiology Clinics|August 4, 2017
How Does Genetics Influence the Efficacy and Safety of Antiarrhythmic Drugs?Katherine T Murray
Journal of Cardiovascular Electrophysiology|May 23, 2009
Why amiodarone is better: another piece of the puzzleKatherine T Murray
Journal of Cardiovascular Electrophysiology|September 17, 2013
It's a funny thing…Katherine T Murray
Journal of Cardiovascular Pharmacology|October 1, 2010
Ionic mechanisms of pacemaker activity in spontaneously contracting atrial HL-1 cellsZhenjiang Yang, Katherine T Murray
Journal of Cardiovascular Electrophysiology|April 11, 2008
When an ICD is not the answer... hypothyroidism-induced cardiomyopathy and torsades de pointesChristopher R Ellis, Katherine T Murray
Journal of Cardiovascular Electrophysiology|September 3, 2010
Preventing atrial fibrillation: more evidence to turn up the heatKatherine T Murray, Lisa C Mace
JAMA|April 5, 2022
Rivaroxaban vs Apixaban and Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation-ReplyWayne A Ray, Katherine T Murray
American Heart Journal|February 28, 2002
Aspirin: redundant in users of nonaspirin, nonsteroidal antiinflammatory agents?Wayne A Ray, Katherine T Murray
Heart Rhythm|March 6, 2007
Nonantiarrhythmic drug therapy for atrial fibrillationKatherine T Murray, Lisa C Mace, Zhenjiang Yang
Frontiers in Physiology|April 28, 2023
Overview of programmed electrical stimulation to assess atrial fibrillation susceptibility in miceMatthew B Murphy, Prince J Kannankeril, Katherine T Murray
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Cardiac Electrophysiology Clinics|August 4, 2017
How Does Genetics Influence the Efficacy and Safety of Antiarrhythmic Drugs?Katherine T Murray
Journal of Cardiovascular Electrophysiology|May 23, 2009
Why amiodarone is better: another piece of the puzzleKatherine T Murray
Journal of Cardiovascular Electrophysiology|September 17, 2013
It's a funny thing…Katherine T Murray
Journal of Cardiovascular Pharmacology|October 1, 2010
Ionic mechanisms of pacemaker activity in spontaneously contracting atrial HL-1 cellsZhenjiang Yang, Katherine T Murray
Journal of Cardiovascular Electrophysiology|April 11, 2008
When an ICD is not the answer... hypothyroidism-induced cardiomyopathy and torsades de pointesChristopher R Ellis, Katherine T Murray
Journal of Cardiovascular Electrophysiology|September 3, 2010
Preventing atrial fibrillation: more evidence to turn up the heatKatherine T Murray, Lisa C Mace
JAMA|April 5, 2022
Rivaroxaban vs Apixaban and Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation-ReplyWayne A Ray, Katherine T Murray
American Heart Journal|February 28, 2002
Aspirin: redundant in users of nonaspirin, nonsteroidal antiinflammatory agents?Wayne A Ray, Katherine T Murray
Heart Rhythm|March 6, 2007
Nonantiarrhythmic drug therapy for atrial fibrillationKatherine T Murray, Lisa C Mace, Zhenjiang Yang
Frontiers in Physiology|April 28, 2023
Overview of programmed electrical stimulation to assess atrial fibrillation susceptibility in miceMatthew B Murphy, Prince J Kannankeril, Katherine T Murray
Pageof 10